In addition, ASNS inhibition promotes aspartate accumulation, activates p53, and suppresses prostate cancer growth by regulating metabolic pathways, DNA repair, cell cycle progression, and apoptosis (22). The gene discussed is TP53; the disease is Familial prostate cancer.